Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 26, 2023

BUY
$5.04 - $8.6 $1,154 - $1,969
229 New
229 $1,000
Q1 2021

Apr 28, 2021

SELL
$13.84 - $17.8 $20,760 - $26,700
-1,500 Closed
0 $0
Q4 2020

Jan 27, 2021

BUY
$12.4 - $17.6 $18,600 - $26,400
1,500 New
1,500 $23,000
Q1 2020

Apr 22, 2020

SELL
$9.31 - $21.24 $9,310 - $21,240
-1,000 Closed
0 $0
Q4 2019

Jan 27, 2020

BUY
$13.91 - $21.48 $13,910 - $21,480
1,000 New
1,000 $20,000
Q3 2019

Oct 31, 2019

SELL
$15.84 - $30.01 $7,920 - $15,005
-500 Closed
0 $0
Q2 2019

Jul 24, 2019

BUY
$17.38 - $26.88 $8,690 - $13,440
500 New
500 $13,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $292M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.